These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7695861)

  • 1. Oestrogens attenuate abnormal coronary vasoreactivity in postmenopausal women.
    Reis SE
    Ann Med; 1994 Dec; 26(6):387-8. PubMed ID: 7695861
    [No Abstract]   [Full Text] [Related]  

  • 2. Oestrogens and postprandial lipid metabolism.
    Westerveld HT; Meyer E; de Bruin TW; Erkelens DW
    Biochem Soc Trans; 1997 Feb; 25(1):45-9. PubMed ID: 9056841
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy and coronary endothelial function in postmenopausal women.
    Singh A
    Mayo Clin Proc; 2005 Jun; 80(6):825; author reply 825-6. PubMed ID: 15945537
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone replacement therapy and coronary artery disease.
    Morris D
    Curr Opin Obstet Gynecol; 1996 Jun; 8(3):184-7. PubMed ID: 8818528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen-only treatment in postmenopausal women.
    Brubaker KL
    JAMA; 2004 Aug; 292(6):686; author reply 686-7. PubMed ID: 15304463
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical aspects of preventing and managing athersclerotic disease in post-menopausal women.
    Sullivan JM
    Eur Heart J; 1996 Aug; 17 Suppl D():32-7. PubMed ID: 8869880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women.
    Tuomikoski P; Mikkola TS
    Ann Med; 2014 Feb; 46(1):1-7. PubMed ID: 24266727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.
    Leiter LA
    Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of postmenopausal hormone replacement.
    Radford N; Church T
    JAMA; 2002 Dec; 288(22):2819; author reply 2823-4. PubMed ID: 12472311
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmenopausal hormone treatment.
    Hulley S; Grady D
    JAMA; 2009 Jun; 301(23):2493-5. PubMed ID: 19531791
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmenopausal hormone therapy and the cardiovascular system.
    Speroff L; Lobo RA
    Heart Dis Stroke; 1994; 3(3):173-6. PubMed ID: 8044433
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen replacement therapy and exercise performance in postmenopausal women with coronary artery disease.
    Collins P; Rosano G
    Am J Cardiol; 1998 Jan; 81(2):259-60. PubMed ID: 9591921
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
    Hulley S
    Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys.
    Appt SE; Clarkson TB; Lees CJ; Anthony MS
    Maturitas; 2006 Sep; 55(2):187-94. PubMed ID: 16574351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary arteriography in estrogen-treated postmenopausal women.
    Sullivan JM
    Prog Cardiovasc Dis; 1995; 38(3):211-22. PubMed ID: 7494883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular protection by oestrogen--a calcium antagonist effect?
    Collins P; Rosano GM; Jiang C; Lindsay D; Sarrel PM; Poole-Wilson PA
    Lancet; 1993 May; 341(8855):1264-5. PubMed ID: 8098404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases].
    Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen replacement therapy.
    Sullivan JM
    Am J Med; 1996 Oct; 101(4A):4A56S-59S; discussion 59S-60S. PubMed ID: 8900338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women, hormones, and clinical trials: a beginning, not an end.
    Miller VM; Clarkson TB; Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Naftolin F; Santoro N
    J Appl Physiol (1985); 2005 Aug; 99(2):381-3. PubMed ID: 16020431
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.